-
1
-
-
73849090193
-
Complement and its role in innate and adaptive immune responses
-
Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20:34-50.
-
(2010)
Cell Res
, vol.20
, pp. 34-50
-
-
Dunkelberger, J.R.1
Song, W.C.2
-
2
-
-
0035810399
-
Complement. First of two parts
-
Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344:1058-1066.
-
(2001)
N Engl J Med
, vol.344
, pp. 1058-1066
-
-
Walport, M.J.1
-
3
-
-
70349437186
-
Complement regulators and inhibitory proteins
-
Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol 2009; 9:729-740.
-
(2009)
Nat Rev Immunol
, vol.9
, pp. 729-740
-
-
Zipfel, P.F.1
Skerka, C.2
-
5
-
-
33645569820
-
Membrane cofactor protein and factor I: Mutations and transplantation
-
Kavanagh D, Goodship TH. Membrane cofactor protein and factor I: Mutations and transplantation. Semin Thromb Hemost 2006; 32:155-159.
-
(2006)
Semin Thromb Hemost
, vol.32
, pp. 155-159
-
-
Kavanagh, D.1
Goodship, T.H.2
-
6
-
-
84855278759
-
Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome
-
Kerr H, Richards A. Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome. Immunobiology 2012; 217:195-203.
-
(2012)
Immunobiology
, vol.217
, pp. 195-203
-
-
Kerr, H.1
Richards, A.2
-
8
-
-
33747159590
-
Genetics of HUS: The impact of MCP CFH, and IF mutations on clinical presentation, response to treatment, and outcome
-
Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: The impact of MCP CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108:1267-1279.
-
(2006)
Blood
, vol.108
, pp. 1267-1279
-
-
Caprioli, J.1
Noris, M.2
Brioschi, S.3
-
10
-
-
53749084348
-
Complement and the atypical hemolytic uremic syndrome in children
-
Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008; 23:1957-1972.
-
(2008)
Pediatr Nephrol
, vol.23
, pp. 1957-1972
-
-
Loirat, C.1
Noris, M.2
Fremeaux-Bacchi, V.3
-
11
-
-
84875382624
-
-
Noris M, Bresin E, Mele C, et al. Atypical hemolytic uremic syndrome. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviews 2011. Seattle University of Washington. This is an excellent review of aHUS. This article describes in detail the clinical presentation, diagnostic work and therapeutic options for the different mutations in complement regulatory proteins.
-
Atypical hemolytic uremic syndrome. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviews 2011. Seattle University of Washington. This is an excellent review of aHUS. This article describes in detail the clinical presentation, diagnostic work and therapeutic options for the different mutations in complement regulatory proteins
-
-
Noris, M.1
Bresin, E.2
Mele, C.3
-
12
-
-
27844566613
-
Atypical haemolytic uraemic syndrome and mutations in complement regulator genes
-
Springer
-
Dragon-Durey MA, Fremeaux-Bacchi V. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes. Springer Semin Immunopathol 2005; 27:359-374.
-
(2005)
Semin Immunopathol
, vol.27
, pp. 359-374
-
-
Dragon-Durey, M.A.1
Fremeaux-Bacchi, V.2
-
13
-
-
0031970553
-
Genetic studies into inherited and sporadic hemolytic uremic syndrome
-
Warwicker P, Goodship TH, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998; 53:836-844.
-
(1998)
Kidney Int
, vol.53
, pp. 836-844
-
-
Warwicker, P.1
Goodship, T.H.2
Donne, R.L.3
-
14
-
-
0019387503
-
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
-
Thompson RA, Winterborn MH. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. Clin Exp Immunol 1981; 46:110-119.
-
(1981)
Clin Exp Immunol
, vol.46
, pp. 110-119
-
-
Thompson, R.A.1
Winterborn, M.H.2
-
15
-
-
20544437666
-
Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome
-
Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16:555-563.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 555-563
-
-
Dragon-Durey, M.A.1
Loirat, C.2
Cloarec, S.3
-
16
-
-
70350279315
-
Atypical hemolytic-uremic syndrome
-
Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:1676-1687.
-
(2009)
N Engl J Med
, vol.361
, pp. 1676-1687
-
-
Noris, M.1
Remuzzi, G.2
-
17
-
-
78649863686
-
Clinical features of antifactor H autoantibody-associated hemolytic uremic syndrome
-
Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features of antifactor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol 2010; 21:2180-2187.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 2180-2187
-
-
Dragon-Durey, M.A.1
Sethi, S.K.2
Bagga, A.3
-
18
-
-
75649133611
-
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI CD46, and C3 in patients with atypical hemolytic uremic syndrome
-
Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010; 115:379-387.
-
(2010)
Blood
, vol.115
, pp. 379-387
-
-
Moore, I.1
Strain, L.2
Pappworth, I.3
-
19
-
-
0242331610
-
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
-
Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003; 100:12966-12971.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 12966-12971
-
-
Richards, A.1
Kemp, E.J.2
Liszewski, M.K.3
-
20
-
-
77958587405
-
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
-
Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5:1844-1859.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1844-1859
-
-
Noris, M.1
Caprioli, J.2
Bresin, E.3
-
21
-
-
19444369542
-
Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome
-
Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004; 41:e84.
-
(2004)
J Med Genet
, vol.41
-
-
Fremeaux-Bacchi, V.1
Dragon-Durey, M.A.2
Blouin, J.3
-
22
-
-
34547633064
-
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome
-
Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007; 18:2392-2400.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2392-2400
-
-
Sellier-Leclerc, A.L.1
Fremeaux-Bacchi, V.2
Dragon-Durey, M.A.3
-
23
-
-
67651166873
-
Thrombomodulin mutations in atypical hemolytic-uremic syndrome
-
Delvaeye M, Noris M, De VA, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:345-357.
-
(2009)
N Engl J Med
, vol.361
, pp. 345-357
-
-
Delvaeye, M.1
Noris, M.2
De, V.A.3
-
24
-
-
54049137505
-
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
-
Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008; 112:4948-4952.
-
(2008)
Blood
, vol.112
, pp. 4948-4952
-
-
Fremeaux-Bacchi, V.1
Miller, E.C.2
Liszewski, M.K.3
-
25
-
-
84860711841
-
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
-
Roumenina LT, Frimat M, Miller EC, et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012; 119:4182-4191.
-
(2012)
Blood
, vol.119
, pp. 4182-4191
-
-
Roumenina, L.T.1
Frimat, M.2
Miller, E.C.3
-
26
-
-
33846094404
-
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
-
Goicoechea de JE, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2007; 104:240-245.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 240-245
-
-
Goicoechea De, J.E.1
Harris, C.L.2
Esparza-Gordillo, J.3
-
28
-
-
84863985862
-
Atypical hemolytic uremic syndrome in children: Complement mutations and clinical characteristics
-
Geerdink LM, Westra D, van Wijk JA, et al. Atypical hemolytic uremic syndrome in children: Complement mutations and clinical characteristics. Pediatr Nephrol 2012; 27:1283-1291.
-
(2012)
Pediatr Nephrol
, vol.27
, pp. 1283-1291
-
-
Geerdink, L.M.1
Westra, D.2
Van Wijk, J.A.3
-
29
-
-
84858776139
-
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations
-
Kavanagh D, Goodship TH. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematology Am Soc Hematol Educ Program 2011; 2011:15-20.
-
(2011)
Hematology Am Soc Hematol Educ Program
, vol.2011
, pp. 15-20
-
-
Kavanagh, D.1
Goodship, T.H.2
-
30
-
-
61549117207
-
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
-
Ariceta G, Besbas N, Johnson S, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009; 24:687-696.
-
(2009)
Pediatr Nephrol
, vol.24
, pp. 687-696
-
-
Ariceta, G.1
Besbas, N.2
Johnson, S.3
-
32
-
-
77957587756
-
Treatment of typical (enteropathic) hemolytic uremic syndrome
-
Bitzan M, Schaefer F, Reymond D. Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36:594-610.
-
(2010)
Semin Thromb Hemost
, vol.36
, pp. 594-610
-
-
Bitzan, M.1
Schaefer, F.2
Reymond, D.3
-
33
-
-
44449165673
-
Successful pretransplant management of a patient with antifactor H autoantibodies-associated haemolytic uraemic syndrome
-
Kwon T, Dragon-Durey MA, Macher MA, et al. Successful pretransplant management of a patient with antifactor H autoantibodies-associated haemolytic uraemic syndrome. Nephrol Dial Transplant 2008; 23:2088-2090.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 2088-2090
-
-
Kwon, T.1
Dragon-Durey, M.A.2
Macher, M.A.3
-
34
-
-
77951621575
-
Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anticomplement factor H autoantibodies
-
Boyer O, Balzamo E, Charbit M, et al. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anticomplement factor H autoantibodies. Am J Kidney Dis 2010; 55:923-927.
-
(2010)
Am J Kidney Dis
, vol.55
, pp. 923-927
-
-
Boyer, O.1
Balzamo, E.2
Charbit, M.3
-
35
-
-
62449341861
-
Autoantibodies in haemolytic uraemic syndrome (HUS)
-
Skerka C, Jozsi M, Zipfel PF, et al. Autoantibodies in haemolytic uraemic syndrome (HUS). Thromb Haemost 2009; 101:227-232.
-
(2009)
Thromb Haemost
, vol.101
, pp. 227-232
-
-
Skerka, C.1
Jozsi, M.2
Zipfel, P.F.3
-
36
-
-
79151471122
-
AHUS caused by complement dysregulation: New therapies on the horizon
-
Waters AM, Licht C. aHUS caused by complement dysregulation: New therapies on the horizon. Pediatr Nephrol 2011; 26:41-57.
-
(2011)
Pediatr Nephrol
, vol.26
, pp. 41-57
-
-
Waters, A.M.1
Licht, C.2
-
37
-
-
59449107473
-
Eculizumab for atypical hemolyticuremic syndrome
-
Nurnberger J, Philipp T, Witzke O, et al. Eculizumab for atypical hemolyticuremic syndrome. N Engl J Med 2009; 360:542-544.
-
(2009)
N Engl J Med
, vol.360
, pp. 542-544
-
-
Nurnberger, J.1
Philipp, T.2
Witzke, O.3
-
39
-
-
58249107188
-
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient
-
Chan MR, Thomas CP, Torrealba JR, et al. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis 2009; 53:321-326.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 321-326
-
-
Chan, M.R.1
Thomas, C.P.2
Torrealba, J.R.3
-
40
-
-
79954443076
-
Eculizumab induces long-term remission in recurrent posttransplant HUS associated with C3 gene mutation
-
Al-Akash SI, Almond PS, Savell VH Jr, et al. Eculizumab induces long-term remission in recurrent posttransplant HUS associated with C3 gene mutation. Pediatr Nephrol 2011; 26:613-619.
-
(2011)
Pediatr Nephrol
, vol.26
, pp. 613-619
-
-
Al-Akash, S.I.1
Almond, P.S.2
Savell Jr., V.H.3
-
41
-
-
79958202220
-
Preemptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome
-
Nester C, Stewart Z, Myers D, et al. Preemptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2011; 6:1488-1494.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 1488-1494
-
-
Nester, C.1
Stewart, Z.2
Myers, D.3
-
42
-
-
80052473232
-
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
-
Weitz M, Amon O, Bassler D, et al. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26:1325-1329.
-
(2011)
Pediatr Nephrol
, vol.26
, pp. 1325-1329
-
-
Weitz, M.1
Amon, O.2
Bassler, D.3
-
43
-
-
77951876953
-
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome
-
Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010; 362:1746-1748.
-
(2010)
N Engl J Med
, vol.362
, pp. 1746-1748
-
-
Zimmerhackl, L.B.1
Hofer, J.2
Cortina, G.3
-
44
-
-
65649106258
-
Liver-kidney transplantation to cure atypical hemolytic uremic syndrome
-
Saland JM, Ruggenenti P, Remuzzi G. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009; 20:940-949.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 940-949
-
-
Saland, J.M.1
Ruggenenti, P.2
Remuzzi, G.3
-
45
-
-
64049101602
-
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome
-
Saland JM, Shneider BL, Bromberg JS, et al. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4:201-206.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 201-206
-
-
Saland, J.M.1
Shneider, B.L.2
Bromberg, J.S.3
-
46
-
-
37549018997
-
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H
-
Jalanko H, Peltonen S, Koskinen A, et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 2008; 8:216-221.
-
(2008)
Am J Transplant
, vol.8
, pp. 216-221
-
-
Jalanko, H.1
Peltonen, S.2
Koskinen, A.3
|